Welcome to our dedicated page for Dassault Systemes news (Ticker: DASTY), a resource for investors and traders seeking the latest updates and insights on Dassault Systemes stock.
Dassault Systèmes SA reports company news centered on its 3DEXPERIENCE platform, virtual twins, and software activity across manufacturing industries, life sciences and healthcare, and infrastructure and cities. Updates commonly cover software revenue, cloud activity, annual run-rate trends, operating cash flow, margin performance, and product themes such as SOLIDWORKS, CENTRIC, 3D UNIV+RSES, and industrial AI.
Company announcements also address shareholder and governance matters, including combined shareholders’ meetings, Universal Registration Document filings with the Autorité des marchés financiers, share repurchase program descriptions, dividend proposals, outstanding share and voting-right declarations, and board leadership changes.
Dassault Systèmes has announced its total number of outstanding shares and voting rights as of January 31, 2021. The company reports a total of 265,165,590 outstanding shares and 397,116,008 voting rights. This calculation includes shares with suspended voting rights, in compliance with the General Regulation of Autorité des marchés financiers. Shareholders are reminded to declare any crossing of threshold notifications to the company's Investor Relations Service.
Dassault Systèmes reported its fourth-quarter and full-year financial results for 2020, showcasing resilience despite the pandemic. Q4 total revenue increased 7% to €1.22 billion (IFRS), with non-IFRS total revenue of €1.22 billion up 5%. FY recurring revenue grew 27% to €3.2 billion, accounting for 80% of total software revenue. The company projects 2021 total revenue growth of 9% to 10%. EPS for the year was €1.86 (IFRS) and €3.77 (non-IFRS), with cash flow from operations rising 5% to €1.24 billion. Strong performance from MEDIDATA and ongoing R&D investments were highlighted.
Medidata, a Dassault Systèmes company, has expanded its partnership with Horizon Therapeutics to enhance clinical trial efficiencies across various therapeutic areas such as ophthalmology, rheumatology, and nephrology. The collaboration builds on a successful relationship that began in 2017. Medidata will provide Horizon with an extensive suite of clinical trial solutions, including the Medidata Rave Clinical Cloud and Intelligent Trials, which utilizes AI for data analytics and performance metrics. This partnership is expected to facilitate faster completion of clinical studies and improve overall trial management.
Dassault Systèmes will announce its third-quarter 2020 results on October 22, 2020. The results will cover the period ending September 30, 2020. A webcast is scheduled for 10:00 AM Paris time and a conference call at 9:00 AM New York time. Both events will be available live and as replays on their investor website. Investors are advised to connect at least fifteen minutes early to ensure they can access the required software. Dassault Systèmes supports over 270,000 customers globally across various industries.
Dassault Systèmes announced the number of outstanding shares and voting rights as of September 30, 2020. The total number of outstanding shares is 264,919,418, while the total voting rights amount to 396,990,201. This information complies with the regulations set by the Autorité des marchés financiers. Shareholders are reminded to refer to Article 223-11 for details regarding the calculation of voting rights, particularly in instances of threshold crossings. Declarations related to threshold crossings should be directed to the Investor Relations Service.